Women's facial hair is a thing: like Adele and Meghan Trainor, we should talk about it and how it changes with age, pregnancy and hormones, whether you prefer threading, IPL or leaving it au naturel
live in the shadows , discussed in hushed tones between salon appointments or slipped into self-care chats with the kind of discretion usually reserved for scandalous gossip. They're the ones everyone deals with but few openly acknowledge, lingering in the unspoken corners of
beauty routines . Women's facial hair sits (perhaps too) comfortably in this category – entirely natural, incredibly common, and yet still treated like a dirty secret.
The reality of peach fuzz, a rogue chin hair or a barely there moustache has been part of womanhood for generations – embraced by some, meticulously removed by others. Whether shaped by genetics, hormones, ageing or conditions such as polycystic ovary syndrome (PCOS), dealing with facial hair remains a fixture in beauty routines yet a ghost in mainstream beauty conversations.
But it's not just the media that avoids the topic; it's often also absent from the coming-of-age discussions that define early self-image. For many, the first upper lip hair or dark chin strand often arrives
alongside periods , breakouts and growth spurts; yet while puberty's other milestones are acknowledged, facial hair is met with silence, leaving many to wonder if it's normal or something to erase in secret.
Advertisement
Facial hair on women has been a largely unspoken issue, but that is changing. Photo: Trunk Archive
Then come the less-talked-about shifts, like post-partum, when a surge in androgens can trigger unexpected hair thickness and coarseness, and menopause, when declining oestrogen lets testosterone take the lead, bringing with it the infamous chin hairs that seem to appear overnight.
The science of facial hair is hardly a mystery. Androgens, often labelled as male hormones, play a major role in hair growth, but they exist in all women at varying levels. 'With virtually any medical process, we are a combination of genetics, diet, relationship, hormones and environment,' explains Dr Bruce Dorr, an American obstetrician-gynecologist and senior medical adviser at preventive medicine company Biote, adding that, when it comes to facial hair, certain populations are genetically predisposed to more noticeable growth in areas that mainstream beauty standards deem undesirable. 'Women of Mediterranean descent, for example, may have hair above the lip and general facial hair because of hormone processing that is genetically driven.'
No Mo-Stache portable lip wax kit. Photo: Handout
Beyond hormones, genetics dictate just how prominent facial hair will be. Dorr explains that testosterone's 'ugly cousin', dihydrotestosterone (DHT), often plays a decisive role. 'There is a certain enzyme that is genetically driven to push testosterone down that pathway. It's the same reason that some men and women lose their hair. It's called 5-alpha reductase, and it turns testosterone into DHT,' a much more potent androgen that causes oily skin, acne, hair growth in places that you don't want it, and hair loss in places where you do.
For some, facial hair increases noticeably in their 30s or 40s – a shift that can feel sudden but is often just another part of the ageing process. 'As we age, our robust and healthy cells get bombarded with bad environmental exposure,' Dorr notes. 'Some of this is a result of our decisions, such as poor diet, but other exposure is simply part of living in our world, such as oestrogenic plastic or disrupters in perfumes and pesticides.'
Flamingo Dermaplane. Photo: Handout
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
31-07-2025
- South China Morning Post
Why is olive oil so expensive now, and how good are alternatives like walnut and avocado?
When it comes to healthy fats, there is nothing better than a bottle of really good extra virgin olive oil. Advertisement Every Mediterranean cuisine relies on its fruity yet bitter taste. The fresh and pungent aroma just smells like a summer holiday. For many chefs, it is a requisite to drizzle a good glug to finish every salad, seafood and pasta dish. At Italian restaurants, I have unconsciously gorged myself on bread and olive oil, leaving no room for my antipasto and pasta. You cannot beat its health properties and antioxidant polyphenols. It is good for your heart, improves your skin and hair, prevents inflammation, and even protects against cancer. The cost of olive oil – and other 'fancy' oils – has risen dramatically in the past few years. Photo: K.Y. Cheng But recently, the price of this 'liquid gold' has shot up significantly. I distinctly recall being able to buy one litre (35 fl oz) bottles for as little as HK$70 in my local supermarket in the 2000s. These days, you would be hard-pressed to find it for less than HK$120, even on sale. Advertisement In some speciality stores, I have been left mouth agape by the staggeringly exorbitant cost of some of the really fancy oils – and I'm not talking about the bottles with edible gold flakes floating inside.
AllAfrica
21-07-2025
- AllAfrica
FDA flags breakdowns at Indian pharma factory exporting to the US
This article was originally published by ProPublica, a Pulitzer Prize-winning investigative newsroom. US inspectors have uncovered new and dangerous breakdowns in drugmaking at an Indian factory owned by Sun Pharma that produces generic medications for American consumers. The latest problems come 2 1/2 years after the Food and Drug Administration gave the facility a special pass to continue sending certain drugs made there to the United States, even after the factory was officially banned from the US market. The factory failed to investigate the source of bacteria found in test vials or deal with damaged equipment that had caused drugs to be contaminated with metal particles, according to the June inspection report, which ProPublica obtained through a Freedom of Information Act request. Workers improperly handled vials and stoppers meant for sterile medications and, in some cases, failed to disinfect manufacturing areas and equipment, according to the report. One FDA inspector saw a worker put on a sterile gown and then brush up against a waste bin and use their hands to push down the overflowing trash. Investigators also saw liquid dripping through ceiling cracks and the growth of what appeared to be fungus and mold in a storage area for samples used for testing. The FDA in late 2022 had banned the factory in the city of Halol from shipping drugs to the United States because of similar manufacturing failures. ProPublica reported last month that a low-profile group inside the agency at the same time exempted some medications from that ban, ostensibly to prevent drug shortages. The FDA has granted similar exemptions for drugs made at more than 20 other foreign factories that violated critical standards in drugmaking and were barred from the US market. The FDA kept the practice largely hidden from the public. The agency did not regularly test drugs coming from the banned factories or proactively monitor reports about potential harm among consumers, ProPublica found. In Sun's case, more than a dozen drugs were initially excluded from the Halol import ban. The company is still allowed to send five to the United States, government records show, including vecuronium bromide, a muscle relaxer used during surgery, and the cancer drug doxorubicin. Also excluded are divalproex delayed release tablets, which treat seizures and other conditions; leuprolide injection, used by people with prostate cancer, endometriosis and other conditions; and temozolomide capsules, for brain cancer. The inspection last month marked the first time the FDA had been back to the factory in the 2.5 years since it imposed the import ban and Sun started sending exempted drugs to the United States. Inspectors found that procedures designed to prevent microbiological contamination of sterile drugs were not established or followed and that equipment wasn't maintained to prevent malfunctions that would 'alter the safety, identity, strength, quality or purity of the drug product,' according to the report. Some of the concerns focused on the exempted drugs still being sent to the United States, according to a person familiar with the situation who did not want to be named because they were not authorized to speak publicly. The FDA blacked out the names of the drugs that were potentially compromised on its publicly released inspection report, including a medication made on a manufacturing line in which several batches had to be rejected because they were filled with black particles. 'It's disappointing to see issues continue to come up at this site given the site's role in potentially manufacturing critical drugs for US consumers,' said the person familiar with the inspection findings. Sun did not respond to questions about the latest inspection or its regulatory history with the FDA. In an email, the company said that adherence to quality standards 'is a top priority for Sun, and we maintain a relentless focus on quality and compliance to ensure the uninterrupted supply of medicines to our customers and patients worldwide. We continue to work proactively with the US FDA and remain committed to achieve full resolution of any FDA regulatory issues at our facilities.' The FDA said factories that receive exemptions from import bans are required to conduct extra testing on drugs with third-party oversight before they are sent to the United States, helping to ensure patient safety. Sun's Halol plant, however, was cited in 2022 and again last month for failing to thoroughly investigate unexplained quality problems, including impurities, found during drug testing. The FDA did not respond to a request for comment about the latest Sun inspection. US Rep. Debbie Dingell, D-Michigan, who recently co-sponsored a bill to lower prescription drug costs, said in a statement to ProPublica that the FDA has a responsibility to ensure that drugs coming into the country are safe. 'We need full transparency about the extent to which exemptions enabled sub-par, unsafe, or ineffective drugs to be distributed to American patients,' she said. Medill Investigative Lab student Katherine Dailey contributed reporting . Sign up to receive ProPublica's biggest stories as soon as they're published.
RTHK
08-07-2025
- RTHK
Kennedy hit by legal blowback over Covid vaccine move
Kennedy hit by legal blowback over Covid vaccine move US Health Secretary Robert F Kennedy Jr has worked to overhaul American vaccination policies since taking office. File photo: Reuters Several leading medical groups have filed suit against US Health Secretary Robert F Kennedy Jr, accusing him of endangering public health with new Covid-19 vaccine recommendations. At the end of May, Kennedy announced via social media that federal authorities would no longer recommend Covid-19 vaccines for children and those who are pregnant, resulting in blowback from health experts. In the lawsuit, the American Academy of Pediatrics, the American College of Physicians and other leading medical groups are calling on the court to stop Kennedy's "unilateral, unscientific" directive and restore Covid-19 vaccines to immunisation schedules. "It is really unconscionable to take away a parent's ability and choice to protect their children through vaccination," said Tina Tan, a pediatrician and president of the Infectious Diseases Society of America, one of the plaintiffs. Since taking office, Kennedy – who spent decades spreading vaccine misinformation before becoming US President Donald Trump's top health official – has worked to overhaul American vaccination policies. In June, he fired all 17 members of the Advisory Committee on Immunisation Practices and appointed his own panelists, under the banner of "Make America Healthy Again". Monday's complaint also highlighted the controversial new appointees to the advisory committee. "We are on a dangerous path," warned Susan Kressly of the American Academy of Pediatrics, denouncing what she described as misinformation spread by Kennedy while citing the concerns of her peers and parents of patients. "Pediatricians cannot stay silent as the system we rely on to support life-saving vaccines is chiseled away piece by piece, with Secretary Kennedy leading efforts to sow doubt and distrust in the American success story of vaccines," Kressly said. The problem isn't limited to parents and children, as misinformation about vaccines undermines a long-standing trust between doctor and patient. Increasingly, medical professionals are finding that adult patients are "hesitant to get their vaccines. They are not trusting the system anymore," said Jason Goldman, president of the American College of Physicians. The issue of vaccines extends beyond Covid-19 in the United States. Johns Hopkins University released a count on Monday finding the US has recorded its worst measles epidemic in more than 30 years, with 1,277 cases confirmed since the beginning of 2025, and illness recorded in 40 of 50 states. The nationwide figure is the highest since 1992. (AFP)
